Martin Siegemund

Martin Siegemund

Company: Pieris Pharmaceuticals

Job title: Senior Scientist


Anticalin Proteins as Key Components in Advanced Multispecific Formats 11:30 am

Serving robust and highly precise building blocks for target binding in therapeutic bi- and multispecific formats Precision targeting and receptor engagement in immuno-oncology can be realized by IgG-Anticalin fusion proteins tailored to the biologic situation Monospecific Anticalin and bispecific Duocalin proteins for inhibition of TNF superfamily receptors in therapy of autoimmune diseases can be endowed…Read more

day: Focus Day Track A - AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.